Abbott Ventricular Tachycardia PAS

Inclusion Criteria

• •1. Patient or legally acceptable representative or parent/guardian (as applicable) must provide written informed consent prior to any clinical investigation-related procedure
• •2. Subjects who have recurrent, drug-refractory, sustained MMVT with non-ischemic structural heart disease and a clinical decision has been made to use FlexAbility SE for an ablation procedure prior to enrollment in the research study
• •3. Refractory (i.e. not effective, not tolerated or not desired) to at least one Class I/III anti-arrhythmic medication for treatment of MMVT
• •4. Implanted with a market released ICD or CRT-D prior to the Index Ablation Procedure
• •5. Able and willing to comply with all study requirements